Factors associated with efavirenz discontinuation in a large community-based sample of patients

AIDS Care
B SpireTRT-5 Group

Abstract

Efavirenz (EFV) is a potent antiretroviral drug; its use may be limited, however, by psychiatric symptoms that require its discontinuation. We sought to identify the characteristics that placed patients at an elevated risk of discontinuation. Data for this cross-sectional study came from a self-administered questionnaire distributed by French AIDS community associations; it collected information about sociodemographic characteristics, addictive behaviours, treatment regimens, EFV history and depression. Patients remaining on EFV for more than six months were compared with those who stopped taking it. Of the 828 patients who completed the questionnaire, 175 had taken EFV for at least six months, and 152 had discontinued it (median months [IQR] of exposure=4[2-10]). Of these 327 patients (median age=42), 23% were women, 46% were unemployed, 38% had a steady sexual partner and 24% reported a history of multiple depressive episodes. Logistic regression showed that the factors independently associated with EFV discontinuation were female gender (OR[95%CI]=2.2[1.2-3.8]), unemployment (1.8[1.1-2.8]), a steady sexual partner (1.7[1-2.5]) and multiple episodes of depression (2.6[1.5-4.5]). Clinicians should keep in mind the neuropsychia...Continue Reading

References

Feb 15, 2001·AIDS Patient Care and STDs·C CederfjällR Wredling
May 3, 2001·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·K A WilsonI F Tannock
Jan 18, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eugenia NegredoBonaventura Clotet
May 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marianne SavèsUNKNOWN Antiprotéases Cohorte (APROCO) Study Group
Jan 7, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Patrizia CarrieriUNKNOWN APROCO Study Group
Apr 3, 2003·HIV Clinical Trials·Luz Martín-CarboneroVincent Soriano

❮ Previous
Next ❯

Citations

Mar 28, 2008·Current HIV/AIDS Reports·Elise D RileyStephen Hwang
May 18, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Valérie JournotUNKNOWN ALIZE Study Group
Nov 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maria Patrizia CarrieriGeorge E Woody
Aug 2, 2005·AIDS Patient Care and STDs·Barbara S Koppel, Chetan Bharel
May 23, 2012·AIDS Patient Care and STDs·E Jennifer EdelmanUNKNOWN Vacs Project Team
Feb 4, 2011·The Journal of Infectious Diseases·Rubin LubomirovUNKNOWN Swiss HIV Cohort Study
Jul 1, 2011·The Journal of Antimicrobial Chemotherapy·Christoph WyenUNKNOWN German Competence Network for HIV/AIDS Coordinators
Jun 4, 2008·AIDS·Rebecca K LodwickAndrew N Phillips
Dec 24, 2013·CNS Drugs·Michael S AbersJoseph S Kass
Dec 12, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Alison J HughesJacek Skarbinski
Nov 6, 2014·The New England Journal of Medicine·Monica Gandhi, Rajesh T Gandhi
Oct 4, 2013·Journal of the International AIDS Society·Mona R LoutfyUNKNOWN Women for Positive Action
Apr 13, 2011·AIDS and Behavior·Christopher A Kenedi, Harold W Goforth
Mar 21, 2007·Expert Opinion on Drug Safety·Gabriele ArendtThorsten Nolting
May 23, 2006·Social Science & Medicine·Asha Persson, Christy Newman
Feb 11, 2009·HIV Clinical Trials·Fabienne MarcellinXavier Anglaret
Jun 26, 2012·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Marysabel Pinto Telis SilveiraLeila Beltrami Moreira
Aug 19, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Glenn J Treisman, Olivia Soudry
Oct 26, 2016·AIDS Research and Treatment·Jacinta Nwamaka NwoguBabafemi Taiwo
Nov 6, 2014·The New England Journal of Medicine·Jessica M Atrio, Kathryn Anastos
Aug 2, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Colette J SmithAndrew N Phillips

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Scandinavian Journal of Infectious Diseases
Julio CollazosMario Loureiro
Expert Opinion on Pharmacotherapy
Saskia M E VrouenraetsJoep M A Lange
© 2022 Meta ULC. All rights reserved